Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus
- PMID: 22973323
- PMCID: PMC3430019
Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus
Abstract
Background: Acute Phase Reactants (APRs) have a wide range of activities that contribute to host defense. The aim of this report was to evaluate the dynamics and magnitude of these proteins in various microvascular complications in diabetes mellitus (DM). We also sought to assess the predictive values of APRs and other clinical variables for microvascular complications in DM.
Methods: This was a case control study carried out in 200 Nigerian subjects with type 2 DM and 100 sex and age matched healthy controls. The studied APRs included C-reactive protein, beta 2 microglobulin, fibrinogen and lipoprotein (a).
Results: The mean values of the APRs were significantly higher in type 2 DM compared with the controls and were observed in higher concentrations in those with microvascular complications, except beta 2 microglobulin. Presence of microvascular complications was observed in those with dilated fundus examination (retinopathy), symptom score of 3.0 (neuropathy), urea and creatinine levels above 50mg% and 1.5mg%, respectively, with significant proteinuria (nephropathy). Significant increase in mean ± SEM values of lipoprotein (a) was observed in diabetic retinopathy in comparison with those without complications (25.76 ± 1.13 mg/dl vs. 22.37 ± 0.73 mg/dl, p = 0.005). Elevated C-reactive protein was observed in diabetic neuropathy in comparison with those without complications (11.43 ± 2.33 u/ml vs. 8.30 ± 1.15 u/ml, p = 0.048). Increased beta 2 microglobulin levels were observed in patients with diabetic foot ulcers in comparison with those without complications (3.04 ± 0.51 mg/dl vs. 2.54 ± 0.14 mg/dl, p = 0.049). Circulating levels of Lipoprotein (a) predicted retinopathy in DM with both good and poor long-term glycemic control while duration of DM predicted the occurrence of foot ulcers..
Conclusions: Increased level of APRs was associated with a number of microvascular complications and may play a role in the pathogenesis.
Keywords: Acute Phase Reactants; Microvascular Complications; Type 2 Diabetes Mellitus.
Conflict of interest statement
Similar articles
-
A Study of the Mean Platelet Volume and Plasma Fibrinogen in Type Two Diabetes Mellitus Patients Versus Healthy Controls and Their Role as Early Markers of Diabetic Microvascular Complications.Cureus. 2024 Jul 26;16(7):e65458. doi: 10.7759/cureus.65458. eCollection 2024 Jul. Cureus. 2024. PMID: 39184698 Free PMC article.
-
Effectiveness of the multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) for diabetic microvascular complications: A population-based cohort study.Diabetes Metab. 2016 Dec;42(6):424-432. doi: 10.1016/j.diabet.2016.07.030. Epub 2016 Aug 24. Diabetes Metab. 2016. PMID: 27568125 Clinical Trial.
-
Association Between Estimated Glomerular Filtration Rate and Microvascular Complications in Type II Diabetes Mellitus Patients: A 1-Year Cross-Sectional Study.J Natl Med Assoc. 2019 Feb;111(1):83-87. doi: 10.1016/j.jnma.2018.06.003. Epub 2018 Jul 20. J Natl Med Assoc. 2019. PMID: 30032867
-
Lipoprotein(a) in type 2 diabetic subjects and its relationship to diabetic microvascular complications.World J Diabetes. 2012 May 15;3(5):105-9. doi: 10.4239/wjd.v3.i5.105. World J Diabetes. 2012. PMID: 22645639 Free PMC article.
-
Complications of Diabetes: An Insight into Genetic Polymorphism and Role of Insulin.Recent Pat Inflamm Allergy Drug Discov. 2018;12(1):78-86. doi: 10.2174/1872213X12666180717165331. Recent Pat Inflamm Allergy Drug Discov. 2018. PMID: 30019654 Review.
Cited by
-
Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus.J Res Med Sci. 2011 Dec;16(12):1634-5. J Res Med Sci. 2011. PMID: 22973376 Free PMC article. No abstract available.
-
Inflammation: therapeutic targets for diabetic neuropathy.Mol Neurobiol. 2014 Feb;49(1):536-46. doi: 10.1007/s12035-013-8537-0. Epub 2013 Aug 30. Mol Neurobiol. 2014. PMID: 23990376 Review.
-
Association between the Prognostic Nutritional Index and Chronic Microvascular Complications in Patients with Type 2 Diabetes Mellitus.J Clin Med. 2023 Sep 13;12(18):5952. doi: 10.3390/jcm12185952. J Clin Med. 2023. PMID: 37762893 Free PMC article.
-
Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts.J Res Med Sci. 2013 Jun;18(6):459-61. J Res Med Sci. 2013. PMID: 24250691 Free PMC article. No abstract available.
References
-
- Crook MA, Tutt P, Simpson H, Pickup JC. Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus. Clin Chim Acta. 1993;219(1-2):131–8. - PubMed
-
- Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 1997;40(11):1286–92. - PubMed
-
- McMillan DE. Further observations on serum viscosity changes in diabetes mellitus. Metabolism. 1982;31(3):274–8. - PubMed
-
- Bergsrand CG, Furst P, Larsson Y, Sterky G. Serum haptoglobin in juvenile diabetes. Scand J Clin Lab Invest. 1962;14:629–32. - PubMed
-
- Ganrot PO, Gydell K, Ekelund H. Serum concentration of alpha-2-macroglobulin, haptoglobin and alpha-1-antitrypsin in diabetes mellitus. Acta Endocrinol (Copenh) 1967;55(3):537–44. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials